Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19.
Newsroom
Dr. Thomas Patterson, chief of infectious diseases and PI of the remdesivir clinical trial site locally, discusses the promising early results of the drug in the fight against COVID-19.